113 related articles for article (PubMed ID: 10028201)
1. Determination of blood serum oncoprotein NEU and antioncoprotein p-53--molecular biomarkers in various types of occupational exposure.
Krajewska B; Lutz W; Piłacik B
Int J Occup Med Environ Health; 1998; 11(4):343-8. PubMed ID: 10028201
[TBL] [Abstract][Full Text] [Related]
2. [Oncoproteins and anti-oncoproteins in blood serum as biomarkers of early health effects induced by occupational and environmental carcinogens].
Lutz W; Krajewska B
Med Pr; 1996; 47(5):511-8. PubMed ID: 9026631
[TBL] [Abstract][Full Text] [Related]
3. [Exposure to asbestos and levels of selected tumor biomarkers].
Krajewska B; Lutz W; Piłacik B
Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
[TBL] [Abstract][Full Text] [Related]
4. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
Amati M; Tomasetti M; Mariotti L; Tarquini LM; Valentino M; Santarelli L
Mutat Res; 2008; 655(1-2):52-8. PubMed ID: 18638565
[TBL] [Abstract][Full Text] [Related]
5. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
6. Determination of tissue polypeptide antigens (TPA) and carcinoembryonic antigen (CEA) in serum: its value in the preliminary cancer risk assessment in asbestos exposed workers.
Lutz W; Krajewska B; Piłacik B
Int J Occup Med Environ Health; 1997; 10(3):259-65. PubMed ID: 9524403
[TBL] [Abstract][Full Text] [Related]
7. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
8. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
Rutowski J; Moszczyński P
Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
10. Oncoproteins as biomarkers of a preclinical form of cancer of the respiratory tract induced by environmental carcinogens.
Lutz W; Sułkowski W; Krajewska B
Pol J Occup Med Environ Health; 1993; 6(4):347-55. PubMed ID: 8019197
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
12. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
[TBL] [Abstract][Full Text] [Related]
13. Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process.
Lutz W; Nowakowska-Swirta E
Int J Occup Med Environ Health; 2002; 15(3):209-18. PubMed ID: 12462448
[TBL] [Abstract][Full Text] [Related]
14. [Genotoxicity effect of chronic lead exposure assessed using the comet assay].
Steinmetz-Beck A; Szahidewicz-Krupska E; Beck B; Poreba R; Andrzejak R
Med Pr; 2005; 56(4):295-302. PubMed ID: 16457366
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentrations of growth factor receptors and Neu in workers previously exposed to asbestos.
Lahat N; Froom P; Kristal-Boneh E; Cohen C; Lerman Y; Ribak J
Occup Environ Med; 1999 Feb; 56(2):114-7. PubMed ID: 10448316
[TBL] [Abstract][Full Text] [Related]
17. [Plasma concentration of selected neoplastic markers in persons occupationally exposed to arsenic and heavy metals].
Szymańska-Chabowska A; Antonowicz-Juchniewicz J; Andrzejak R
Med Pr; 2004; 55(4):313-20. PubMed ID: 15620040
[TBL] [Abstract][Full Text] [Related]
18. The biomarkers detecting early changes in the human organism exposed to occupational carcinogens.
Indulski JA; Lutz W
Cent Eur J Public Health; 1999 Nov; 7(4):221-4. PubMed ID: 10659387
[TBL] [Abstract][Full Text] [Related]
19. [Anti-p53 antibodies as markers of carcinogenesis in exposures to vinyl chloride].
Mocci F; De Biasio AL; Nettuno M
G Ital Med Lav Ergon; 2003; 25 Suppl(3):21-3. PubMed ID: 14979067
[TBL] [Abstract][Full Text] [Related]
20. [Studies on serum regulatory protein for cell growth in patients with lung cancer exposed to indoor coal-burning].
Li J; Li X; Quan X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):92-4. PubMed ID: 9812620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
